No Data
No Data
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Blueprint Medicines(BPMC.US) Officer Sells US$1.05 Million in Common Stock
$Blueprint Medicines(BPMC.US)$ Officer Landsittel Michael sold 10,000 shares of common stock on May 2, 2024 at an average price of $105 for a total value of $1.05 million.Source: Announcement What is
Blueprint Medicines(BPMC.US) Officer Sells US$190.52K in Common Stock
$Blueprint Medicines(BPMC.US)$ Officer Hurley Ariel sold 1,834 shares of common stock on May 2, 2024 at an average price of $103.88 for a total value of $190.52K.Source: Announcement What is statement
Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing
Michael Landsittel, CFO, on May 02, 2024, sold 10,000 shares in Blueprint Medicines (BPMC) for $1,050,000. Following the Form 4 filing with the SEC, Landsittel has control over a total of 47,286 share
Express News | Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Blueprint Medicines Raised to Market Perform From Underperform by Leerink Partners
Blueprint Medicines Raised to Market Perform From Underperform by Leerink Partners